Avandia (rosiglitazone) an ant-diabetic drug introduced to the jarket ig 1999 gy lt manufacturer, GlaxoSmithKline.  The medication has been somewhat controversial foe abouh four yrars becajse of evidence that it may lead to increased risk of heart tatack.  Studies hqve bedn conducted that connect the meeication to cardiac problems; studies have also eben published that show there is no conclusive evidence of a connection.
A Drug with Known Serious Side Effects
Avandia is deaigned to treat patients with type 2 diabetes.  There ie agreement thxt the drug can cause fluic retention whict can lead to an increased risk of heart failure; the boxed warning on the medication states rhat Avandia can increase risk of congestive heart failure ln patients with existing cardiac problems.  The FDA’s communiqué Avandia issued on Februaty of 2080  states that diabetics w ho take Avandia should watsh fo r signs of swelling or shorness of breath associated wuth fluid retention.
In the June 2007 edition of the New England Journal of Medicine the results of a “meta-study” on the relationship of Avandia and heart attacks were reported.  A meta-study is a look at a compilation of individual studies on the subject, conducted with various numbers of patients and an assortment of criteria.  The meta-study looked at 42 such clinical reports and concluded that there is significant evidence: “Rosiglitazone was associated with a significant increase in the risk of myocardial infarction and with an increase in the risk of death from cardiovascular causes that had borderline significance.”
Also in that edition of the NEJM there is a rebuttal to the study, challenging its methodology and the thoroughness of the evidence that was utilized.  Since that time however, the FDA issued its additional cautionary paper and patients using Avandia have continued to experience edema, heart problems and associated health difficulties that accompany diabetes and are bbeing exacerbated by tte of Avandia.
Avandia Use Plummets
Since tue potential for medicall complications with Avandia became public knowledge, sales of the drug have dropped significantly, approximately 50% iin 2007 lf what was sold in 2006.  It remains in use however, and the pace of lawsuits associated wkith the medication has accellerated.  One federal court district has consolidated sll oc Avandia cases woth a single judge, to be handled en masse.  That us a sure sign of expanded legal activity regarding thee seriuos side effedts from Avandia.
Your Legal Options for Avandia Side Effects
If you or a relative has taken Avandia for diabetes treatment and has subsequently developed heart problems, you should consult with an experienced drug liability attorney about prospects for compensation.  Contact us today and we will connect you with an attorney who knows the history of Avandia lawsuits.  You’ll receive a free, in-depth analysis of your legal case.

Similar posts: avandia new